Late-stage trials of an advanced malaria vaccine candidate—which, if approved, would become the world’s first malaria vaccine—are under way. This article, published in Health Affairs, recounts the pivotal roles played by collaborations of nonprofit organizations, pharmaceutical companies, private and public donors, and countries whose citizens would benefit most directly from a vaccine.

Author(s): Loucq C, Birkett A, Poland D, Botting C, Nunes J, Ethelston S

Corporate author(s): PATH

Publication date: June 2011

Available materials


Producing a Successful Malaria Vaccine

(Located at

Hard copies are not available.

Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.

Related regions: Africa

See also:

For more information…

Contact: PATH Publications
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA